Solid Biosciences Inc. (SLDB)
NASDAQ · Healthcare
Solid Biosciences Inc. Operating Income 2016–2022
Solid Biosciences Inc. annual/quarterly operating income history and growth rate from 2016 to 2020. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Solid Biosciences Inc. operating income for the quarter ending September 30, 2020 was -21.2 M, a 28.57% decrease year-over-year.
- Solid Biosciences Inc. operating income for the twelve months ending September 30, 2020 was -96.8 M, a 2.30% increase year-over-year.
- Solid Biosciences Inc. annual operating income for 2022 was -106.5 M, a 47.33% increase from 2021.
- Solid Biosciences Inc. annual operating income for 2021 was -72.3 M, a 18.27% decrease from 2020.
- Solid Biosciences Inc. annual operating income for 2020 was -88.4 M, a 25.91% decrease from 2019.
- Solid Biosciences Inc. annual operating income for 2019 was -119.3 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Solid Biosciences Inc. Operating Income — FAQ
Solid Biosciences Inc. (SLDB) operating income over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
What is Solid Biosciences Inc.'s operating income?
Solid Biosciences Inc. (SLDB) reported operating income of -$106M for fiscal 2022.
Where can I see SLDB's operating income history?
The chart and table above show Solid Biosciences Inc.'s operating income by year and by quarter, including the growth rate.